Company / Operating Margin
IOVANCE BIOTHERAPEUTICS, INC. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-153.1%
FY2025
5-year range
-38735.0% / -153.1%
FY2023-FY2025
Trend
+36.5%
vs FY2024
Sector context
#92 of 135
Health Care
What the data says
At -153.1%, IOVANCE BIOTHERAPEUTICS, INC.'s operating margin ranks #92 of 135 in the Health Care sector. Improved from -38735.0% to -153.1% over the past 2 years.
Based on SEC 10-K filings.
-153.1% in FY2025.
Improved from -38735.0% to -153.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#92 of 135 in Health CareTop 68% of 135This company -153.1% Sector average -774.4%
▼
+80.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 36.5% year-over-year.
- Currently 621.4pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -153.1% | +36.5% |
| FY2024 | -240.9% | +99.4% |
| FY2023 | -38735.0% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026